173 related articles for article (PubMed ID: 33961183)
21. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.
Yoon YH; Kim HJ; Lee JW; Kim JM; Koo BS
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1013-7. PubMed ID: 21822854
[TBL] [Abstract][Full Text] [Related]
22. Capsular Invasion Matters Also in "Papillary Patterned" Tumors: A Study on 121 Cases of Encapsulated Conventional Variant of Papillary Thyroid Carcinoma.
Akbulut D; Kuz ED; Kursun N; Dizbay Sak S
Endocr Pathol; 2021 Sep; 32(3):357-367. PubMed ID: 33398670
[TBL] [Abstract][Full Text] [Related]
23. Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma: A retrospective study.
Yuan J; Li J; Chen X; Zhong Z; Chen Z; Yin Y; Du J; Cong S; Wu Z
Medicine (Baltimore); 2017 Sep; 96(35):e7908. PubMed ID: 28858110
[TBL] [Abstract][Full Text] [Related]
24. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J
Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442
[TBL] [Abstract][Full Text] [Related]
25. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
26. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
27. [Risk factors of level Ⅵ lymph node metastasis in cN0 papillary thyroid carcinoma].
Ma N; Li JR; Guo HG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(8):641-644. PubMed ID: 29871097
[No Abstract] [Full Text] [Related]
28. Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.
Zhang F; Zheng B; Yu X; Wang X; Wang S; Teng W
Front Endocrinol (Lausanne); 2021; 12():675643. PubMed ID: 34322091
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
Aragon Han P; Weng CH; Khawaja HT; Nagarajan N; Schneider EB; Umbricht CB; Witwer KW; Zeiger MA
Thyroid; 2015 Dec; 25(12):1322-9. PubMed ID: 26414548
[TBL] [Abstract][Full Text] [Related]
30. A case-control study on the association of mineral elements exposure and thyroid tumor and goiter.
Liu M; Song J; Jiang Y; Liu Y; Peng J; Liang H; Wang C; Jiang J; Liu X; Wei W; Peng J; Liu S; Li Y; Xu N; Zhou D; Zhang Q; Zhang J
Ecotoxicol Environ Saf; 2021 Jan; 208():111615. PubMed ID: 33396135
[TBL] [Abstract][Full Text] [Related]
31. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
32. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
Lee G; Kang YE; Oh C; Liu L; Jin Y; Lim MA; Won HR; Chang JW; Koo BS
Auris Nasus Larynx; 2020 Oct; 47(5):870-880. PubMed ID: 32381353
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
34. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
35. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
36. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
37. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
38. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
39. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
40. Association between TNM staging system and histopathological features in patients with papillary thyroid carcinoma.
Baek HJ; Kim DW; Ryu JH
Endocrine; 2015 Mar; 48(2):589-94. PubMed ID: 25052062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
